Safety and efficacy of bevacizumab combined with R-CHOP regimen in seven Chinese patients with untreated diffuse large B-cell lymphoma.
Autor: | Zhiying Fu1 fzying123@126.com, Jun Zhu1 zj@bjcancer.org, Wen Zheng1 zhengwen610824@163.com, Weiping Liu1 dreaming2217@sina.com, Zhitao Ying1 yingzhitao001@163.com, Yan Xie1 xieyan9@263.net, Xiaopei Wang1 cadillac570@163.com, Ningjing Lin1 lnjlzm@126.com, Meifeng Tu1 shengyousong@yahoo.com.cn, Lingyan Ping1 dingdingply1981@163.com, Lijuan Deng1 9546411@qq.com, Chen Zhang1 xiaofuer134@sina.com, Ning Ding1 frank.ding.ning@gmail.com, Yuqin Song1 songyuqin622@sina.com |
---|---|
Zdroj: | Cancer Cell International. 2014, Vol. 14 Issue 1, p1-14. 14p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |